Hamid R. Rabiee

AUG 13, 2026 · JOURNAL ARTICLE

Shedding light on neural learning to rank models for anticancer drug prioritization

PLOS One

This is a benchmarking and methods development study using machine learning on existing drug-screening datasets with no prospective validation, clinical outcomes, or independent test cohort, demonstrating feasibility and interpretability of neural ranking models rather than efficacy.